BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26640389)

  • 61. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer.
    Sugarbaker PH
    J Surg Oncol Suppl; 1993; 3():158-60. PubMed ID: 8503973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
    Botticelli A; Cirillo A; Scagnoli S; Cerbelli B; Strigari L; Cortellini A; Pizzuti L; Vici P; De Galitiis F; Di Pietro FR; Cerbelli E; Ghidini M; D'Amati G; Della Rocca C; Mezi S; Gelibter A; Giusti R; Cortesi E; Ascierto PA; Nuti M; Marchetti P
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32353934
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutaneous metastases of internal malignancies: a clinicopathologic study.
    Chopra R; Chhabra S; Samra SG; Thami GP; Punia RP; Mohan H
    Indian J Dermatol Venereol Leprol; 2010; 76(2):125-31. PubMed ID: 20228540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
    Jung GW; Dover DC; Salopek TG
    Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Late metastases of cutaneous malignant melanoma.
    Steiner A; Wolf C; Pehamberger H; Wolff K
    Br J Dermatol; 1986 Jun; 114(6):737-40. PubMed ID: 3718866
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A rational approach to the follow-up of melanoma patients.
    Garbe C
    Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.
    Thorstensen L; Qvist H; Heim S; Liefers GJ; Nesland JM; Giercksky KE; Lothe RA
    Neoplasia; 2000; 2(6):514-22. PubMed ID: 11228544
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting metastatic breast cancer: problems and potential.
    Deasy S; Szczepanek K; Hunter KW
    F1000 Fac Rev; 2015; 4():. PubMed ID: 33842931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of early dissemination and metastasis in Her2
    Harper KL; Sosa MS; Entenberg D; Hosseini H; Cheung JF; Nobre R; Avivar-Valderas A; Nagi C; Girnius N; Davis RJ; Farias EF; Condeelis J; Klein CA; Aguirre-Ghiso JA
    Nature; 2016 Dec; 540(7634):588-592. PubMed ID: 27974798
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A single thyroid nodule revealing early metastases from clear cell renal carcinoma: case report and review of literature.
    Di Furia M; Della Penna A; Salvatorelli A; Clementi M; Guadagni S
    Int J Surg Case Rep; 2017; 34():96-99. PubMed ID: 28376423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy.
    Neophytou CM; Kyriakou TC; Papageorgis P
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817646
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
    Hanin L; Bunimovich-Mendrazitsky S
    Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data.
    Junker K; Moravek P; Podhola M; Weirich G; Hindermann W; Janitzky V; Schubert J
    Int J Oncol; 2000 Nov; 17(5):903-8. PubMed ID: 11029490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early tumor dissemination, but late metastasis: insights into tumor dormancy.
    Röcken M
    J Clin Invest; 2010 Jun; 120(6):1800-3. PubMed ID: 20501952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Eukaryotic cell encystation and cancer cell dormancy: is a greater devil veiled in the details of a lesser evil?
    Baig AM; Khan NA; Abbas F
    Cancer Biol Med; 2015 Mar; 12(1):64-7. PubMed ID: 25859414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.